Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

144.10
Delayed Data
As of Jul 21
 -0.20 / -0.14%
Today’s Change
95.14
Today|||52-Week Range
147.45
+27.88%
Year-to-Date

Today’s Trading

Previous close144.30
Today’s open144.08
Day’s range142.91 - 145.20
Volume290,782
Average volume (3 months)287,617
Market cap$6.3B
Dividend yield--
Data as of 07/21/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+56.89%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+35.13%
P/E ratio123.2
Price/Sales12.56
Price/Book13.92

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc-0.49-0.70%
WSTWest Pharmaceutical ...-0.48-0.51%
MASIMasimo Corp-1.08-1.11%
IARTIntegra LifeSciences...-0.66-1.18%
Data as of 07/21/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$0.42
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts